Alcon AG

Alcon is a healthcare company with a brilliant vision. This healthcare manufacturer develops and sells products for all types of eye conditions. Being a global leader in vision healthcare, Alcon holds bragging rights as the largest eye care device company in the world. Their products and services are offered in 140 out of 195 countries in the world.

$94.75
(as of Mar 27, 10:00 AM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for Alcon AG

Stock Price
$94.75
Ticker Symbol
ALC
Exchange
NYSE

Industry Information for Alcon AG

Sector
Healthcare
Industry
Medical Instruments & Supplies

Company Description for Alcon AG

Country
USA
Full Time Employees
25,599

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, grieshaber, MIVS instruments, scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Fundamentals for Alcon AG

Market Capitalization
$45,900,365,824
EBITDA
$2,500,999,936
Dividends per Share
$0.31
P/E Ratio
45.27
Forward P/E Ratio
28.74
Earnings per Share
$2.05
Earnings per Share Estimate Next Year
Profit Margin
10.27%
Shares Outstanding
494,616,000
Percent Owned by Insiders
0.13%
Percent Owned by Institutions
75.11%
52-Week High
52-Week Low

Technical Indicators for Alcon AG

50-Day Moving Average
200-Day Moving Average
RSI
51.84
1.72

Analyst Ratings for Alcon AG

Strong Buy
17
Buy
6
Hold
3
Sell
1
Strong Sell
0

News About Alcon AG

Mar 26, 2025, 4:30 PM EST
Leverages Alcon’s global scale with Aurion’s cell therapy expertise to accelerate U.S. See more.
Mar 25, 2025, 3:10 PM EST
A Relative Strength Rating upgrade for Alcon shows improving technical performance. See more.
Mar 25, 2025, 9:00 AM EST
https://www.tipranks.com/news/the-fly/morning-movers-23andme-plummets-after-chapter-11-proceedings-and-ceo-exit See more.
Mar 25, 2025, 8:44 AM EST
Alcon ALC recently announced that its Clareon Vivity intraocular lens (IOL), featuring extended depth of focus (EDOF) technology, has received CE Mark approval. See more.